Acta Med. 2010, 53: 243-246
https://doi.org/10.14712/18059694.2016.85
A Case of Disproportionate Macrodactyly or a Mild form of Proteus Syndrome? An Interesting Case
References
1. Am J Med Genet 1999; 84: 389–95.
< LG, Happle R, Mulliken JB et al. Proteus syndrome: diagnostic criteria, differential diagnosis, and patient evaluation. https://doi.org/10.1002/(SICI)1096-8628(19990611)84:5<389::AID-AJMG1>3.0.CO;2-O>
2. Am J Med Genet C Semin Med Genet. 2005; 137C(1): 38–52.
< MM Jr. Proteus Syndrome: an update. https://doi.org/10.1002/ajmg.c.30063>
3. Birth Defects 1979; 15: 291–296.
MM Jr, Hayden PW. A newly recognized hamartomatous syndrome.
4. Clin Exp Dermatol 2004; 29: 222–30.
< PH, Martinez A, Maerker J, Harper JI. Vascular anomalies in Proteus syndrome. https://doi.org/10.1111/j.1365-2230.2004.01513.x>
5. Dysmorphol Clin Genet 1990; 4: 87.
GS. Proteus syndrome and hamartoses with overgrowth.
6. Am J Med Genet 2004; 130A: 111–22.
< JT, Cohen MM Jr, Biesecker LG. Reassessment of the Proteus syndrome literature: application of diagnostic criteria to published cases. https://doi.org/10.1002/ajmg.a.30327>
7. Arch Dermatol 2004; 140: 947–53.
D, Turner JT, Olsen C, et al. Cutaneous manifestations of proteus syndrome: correlations with general clinical severity.
8. Mod Pathol 2002; 15: 172–80.
< RR, Hart WR, Magnuson DK, et al. Genital tract tumors in Proteus syndrome: report of a case of bilateral paraovarian endometrioid cystic tumors of borderline malignancy and review of the literature. https://doi.org/10.1038/modpathol.3880510>
9. Arch Dermatol 1989; 125: 1109–14.
< CP, Levin SW, James WD, Benson PM, Walker JC, Perlik PC. Proteus syndrome. https://doi.org/10.1001/archderm.1989.01670200085015>
10. Pediatr Dermatol 1988; 5: 14–21.
< DL, Saxe N, Temple-Camp C. Cutaneous manifestations of the Proteus syndrome. https://doi.org/10.1111/j.1525-1470.1988.tb00878.x>
11. Eur J Pediatr 1983; 140: 5–12.
< HR, Burgio GR, Aldenhoff P, et al. The Proteus syndrome: partial gigantism of the hand and /or feet, nevi, hemihypertrophy, subcutaneous tumours, macrocephaly or other skull anomalies and possible accelerated growth and visceral affections. https://doi.org/10.1007/BF00661895>